NADPH
Nicotinamide Adenine Dinucleotide(NAD), reduced nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADP), and reduced nicotinamide adenine dinucleotide phosphate (NADPH) have been known as classic molecules involving in energy metabolism, reductive biosynthesis, and antioxidation. Structurally NADP is identical to NAD except for the additional 2’ phosphate on the adenosine ribose moieties of NADP. However, NAD (including NAD and NADH) are mainly used by the enzymes that catalyze substrate oxidation, while NADP (including NADP and NADPH) are mainly used by the enzymes that catalyze substrate reduction. Recent studies have indicated pivotal roles of NAD-dependent histone deacetylases (i.e., sirtuins) in aging; b) poly(ADP-ribose) polymerase-1 (PARP-1)—-a major NAD-consuming enzyme—-appears to mediate oxidative cell death under many conditions; c) cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP)—-two endogeneous molecules generated from NAD—-are key signaling molecules mobilizing intracellular calcium stores; and d) NADPH oxidase is a major generator of reactive oxygen species (ROS) in both immunological reactions and multiple diseases. NAD may affect gene expression through several pathways.
NADH mediates the activity of the corepressor carboxyl-terminal binding protein—-a transcriptional factor important for cell cycle regulation, development, and transformation and NADH also modulates the activities of Clock:BMAL1 and NPAS2:BMAL1 that are heterodimeric transcription factors controlling circadian clock-associated gene expression. Selective inhibition of NAD synthesis has been shown to induce apoptosis of tumor cells. Because PARP-1 plays critical roles in regulating DNA repair, genomic stability, and cell cycle progression, many studies have been conducted to determine the roles of PARP-1 in carcinogenesis. Because NAD and NADP can profoundly affect cell death and various biological processes including gene expression and signal transduction, future studies may further elucidate important roles of NAD and NADP in carcinogenesis and cancer treatment.
NADH mediates the activity of the corepressor carboxyl-terminal binding protein—-a transcriptional factor important for cell cycle regulation, development, and transformation and NADH also modulates the activities of Clock:BMAL1 and NPAS2:BMAL1 that are heterodimeric transcription factors controlling circadian clock-associated gene expression. Selective inhibition of NAD synthesis has been shown to induce apoptosis of tumor cells. Because PARP-1 plays critical roles in regulating DNA repair, genomic stability, and cell cycle progression, many studies have been conducted to determine the roles of PARP-1 in carcinogenesis. Because NAD and NADP can profoundly affect cell death and various biological processes including gene expression and signal transduction, future studies may further elucidate important roles of NAD and NADP in carcinogenesis and cancer treatment.
Membrane Transporter/Ion Channel
AMPK(58)
ASBT Transporter(6)
BCRP(10)
Beta Amyloid(69)
Carbonic Anhydrase(40)
Chloride Channel(34)
CRAC Channel(0)
CRM1(5)
Exportin-1(5)
FABP(6)
GAT(63)
GLUT(5)
Glutamate Transporter(1)
GlyT(13)
HCN Channel(5)
iGluR(52)
Monoamine Transporter(26)
Monocarboxylate Transporter(12)
MTP(1)
nAChR(5)
NADPH(35)
Na-K-ATPase(2)
NKCC(4)
NMDAR(65)
OCT(4)
Other Targets(13)
P2X Receptor(23)
P-glycoprotein(14)
Proton Pump(38)
Sodium Channel(147)
TRP/TRPV Channel(115)
URAT1(1)
NADPH
-
Aucuparin
catalog no : M37763
cas no: 3687-28-3
Aucuparin (2,6-dimethoxy-4-phenylphenol) is a plant antibiotic with anti-inflammatory activity. Aucuparin inhibited pulmonary fibrosis in mouse models induced by bleomycin (BLM). -
NecroX-7 B
catalog no : M37704
cas no: 1120332-55-9
NecroX-7 (LC-280126) is a potent free radical scavenger and HMGB1 (high-mobility group box 1) inhibitor. -
gp91 ds-tat
catalog no : M37261
cas no: 329902-61-6
gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression. -
Casein kinase 1δ-IN-9
catalog no : M35815
cas no: 854355-54-7
Casein kinase 1δ-IN-9 is a Quinone reductase 2 inhibitor with IC50 of 0.6μM. -
HTS07545
catalog no : M35541
cas no: 118666-03-8
HTS07545 is a potent sulfide:quinone oxidoreductase inhibitor (IC50: 30 nM) that reduces the rate of hydrogen sulfide (H2S) decomposition and has been used in heart failure studies.